These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 32462761)
1. Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR. Tam LS; Tanaka Y; Handa R; Chang CC; Cheng YK; Isalm N; Li M; Lorenzo JP; Song YW; Yamamoto K; Zeng X; Haq SA Int J Rheum Dis; 2020 Jun; 23(6):717-722. PubMed ID: 32462761 [No Abstract] [Full Text] [Related]
2. Rheumatology in a time of Coronavirus: lessons from our early experiences. Cronin O; Horne A; Ralston SH QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603 [No Abstract] [Full Text] [Related]
3. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic. Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135 [No Abstract] [Full Text] [Related]
4. COVID-19: a primer for the rheumatologist: management of patients and care settings. Calabrese C; Lehman B Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823 [TBL] [Abstract][Full Text] [Related]
5. How to manage rheumatic patients during the coronavirus pandemic. Parisi S; Ditto MC; Finucci A; Fusaro E Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511 [No Abstract] [Full Text] [Related]
6. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy. Quartuccio L; Valent F; Pasut E; Tascini C; De Vita S Joint Bone Spine; 2020 Oct; 87(5):439-443. PubMed ID: 32445935 [TBL] [Abstract][Full Text] [Related]
7. How did COVID-19 pandemic changed the Portuguese rheumatology? Vieira-Sousa E; Fonseca JE; Santos MJ Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820 [No Abstract] [Full Text] [Related]
9. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Robinson PC; Yazdany J Nat Rev Rheumatol; 2020 Jun; 16(6):293-294. PubMed ID: 32242121 [TBL] [Abstract][Full Text] [Related]
10. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260 [TBL] [Abstract][Full Text] [Related]
11. Translating IL-6 biology into effective treatments. Choy EH; De Benedetti F; Takeuchi T; Hashizume M; John MR; Kishimoto T Nat Rev Rheumatol; 2020 Jun; 16(6):335-345. PubMed ID: 32327746 [TBL] [Abstract][Full Text] [Related]
12. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments]. Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A; Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Seo MR; Kim JW; Park EJ; Jung SM; Sung YK; Kim H; Kim G; Kim HS; Lee MS; Lee J; Hur JA; Chin BS; Eom JS; Baek HJ; Korean J Intern Med; 2020 Nov; 35(6):1317-1332. PubMed ID: 32972125 [TBL] [Abstract][Full Text] [Related]
16. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619 [No Abstract] [Full Text] [Related]
17. Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19. Gazzaruso C; Carlo Stella N; Mariani G; Tamburlini A; Garini P; Freddi E; Ravetto C; Coppola A; Gallotti P Clin Rheumatol; 2020 Aug; 39(8):2475-2477. PubMed ID: 32548723 [No Abstract] [Full Text] [Related]
18. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399 [TBL] [Abstract][Full Text] [Related]
19. Mortality surveillance during the COVID-19 pandemic. Setel P; AbouZahr C; Atuheire EB; Bratschi M; Cercone E; Chinganya O; Clapham B; Clark SJ; Congdon C; de Savigny D; Karpati A; Nichols E; Jakob R; Mwanza J; Muhwava W; Nahmias P; Ortiz EM; Tshangela A Bull World Health Organ; 2020 Jun; 98(6):374. PubMed ID: 32514207 [No Abstract] [Full Text] [Related]
20. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic. Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]